Trial intelligence / Profile preview

Remimazolam tosylate vs midazolam for ICU mechanical ventilation sedation

ChiCTR2100049067Phase 4Not yet recruiting

Sponsor
Henan Provincial People's Hospital
Start
Aug 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in Requirement for mechanical ventilation (MV) (2 arms), sponsored by Henan Provincial People's Hospital. Primary endpoint: Rate of achieving sedation goals with a single medication. Planned start Aug 2021; status: not yet recruiting.

02

Drugs

remimazolam
03

Conditions

Requirement for mechanical ventilation (MV)

Beyond the preview

Go deeper on ChiCTR2100049067.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100049067.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call